phase readout
saveNCT04702880: A Study of BMS-986012 in Combination With Carboplatin, Etoposide, and Nivolumab as First-line Therapy in Extensive-stage Small Cell Lung Cancer
COMPLETEDupdated 1mo ago
community read0 votes
Sponsor: Bristol-Myers Squibb. Phase: PHASE2. Conditions: Extensive-stage Small Cell Lung Cancer
view source ↗
comments(0)
5-min edit window · permanent after that